Picklive IPO: Fantasy football firm plans £10m Aim float November 3, 2014 Fantasy sports operator Picklive will announce plans this morning to raise £5m through a listing on London’s Alternative Investment Market (Aim) that will value the firm at £10m. Picklive’s fantasy games cover football, baseball and American football where players pick and bet on a team based on real-life players, get points based on player’s performance [...]
Spanish government puts off Aena IPO until at least next year October 31, 2014 The heavily-trailed flotation of the world's largest airport operator has been postponed until at least the early part of next year, a source close to the deal has confirmed. Spanish government-owned Aena, which owns 46 airports including Luton, Madrid Cuartro-Vientos and Barcelona-El Prat, had been due to list 49 per cent of its shares on November [...]
Fiat Chrysler share price soars as Ferrari IPO spin-off plans revealed October 30, 2014 Fancy owning a chunk of one of the best known luxury sports car brands out there? Ferrari is being spun off by its parent company Fiat Chrysler Automobiles (FCA) as it looks to ensure the group's “long-term success”, it was revealed today. The spin off will include an IPO, with around 10 per [...]
Ferrari revs up blockbuster stock market flotation in US next year October 29, 2014 FERRARI is set to float on the stock market next year after its owner Fiat-Chrysler unveiled plans to spinout the iconic car-maker as a publicly listed company. The Italian luxury marque, founded by Enzo Ferrari in 1947, will list 10 per cent of shares in the US as part of a fundraising exercise by Fiat-Chrysler. [...]
Riverstone Energy share price rises as firm reveals $13m profit in third quarter one year after IPO October 29, 2014 Shares in Riverstone Energy rose by 1.5 per cent yesterday after its third quarter results revealed a $13.4m (£8.3m) profit. Riverstone stated that it had assessed numerous potential exploration, production and midstream investments since last October, with nine made so far. Pierre Lapeyre, co-founder of Riverstone, commented: “While all nine investments are still in their [...]
How a single comment cost Royal Bank of Canada millions of dollars in fees from Alibaba’s IPO October 29, 2014 One banker will be keeping his or her mouth shut for a while to come after, let’s say a slight snafu, ended up costing their employer millions of dollars. The loose-lipped, unnamed banker at Royal Bank of Canada apparently let slip a comment about Alibaba during a webinar. No biggie, surely – unless the bank [...]
Profits up after Citizens Bank’s market flotation October 27, 2014 CITIZENS bank reported healthy profit growth yesterday in its first set of quarterly results since RBS sold off a 25 per cent stake in the US retail lender. Net income came in at $189m (£117m) for the three-month period, up 31 per cent on the $144m in the same quarter of 2013. Revenues were up [...]
Volution Group results strong for first post-IPO report October 23, 2014 Fan manufacturer Volution Group has reported an 18 per cent increase in revenue during 2014, from £102m to £121m. Of this total, the company’s ventilation segment posted revenue of £101m, up 23 per cent on last year. The firm also reported a pre-tax loss of £15.5m, compared with a £4.2m loss in 2013. These [...]
GlaxoSmithKline considers £17bn HIV wonder drugs split with Viiv Healthcare IPO October 22, 2014 Pharma giant GlaxoSmithKline (GSK) is considering floating its HIV drugs business in a move that would see Viiv Healthcare among the top 40 companies in the FTSE 100 with a market valuation of up to £17bn. Chief executive Andrew Witty told reporters yesterday: “In line with our commitment to identifying ways to realise shareholder value, [...]
GSK healthcare spin-off ViiV could generate one of the biggest IPOs in history: Here are some of the most successful corporate spin-offs stories October 22, 2014 ViiV Healthcare could generate one of the biggest IPOs in history, if GSK decides to go ahead and make it a spin-off company. The pharmaceutical firm was created in 2009 as a joint venture between GSK and US firm Pfizer. It specialises in developing therapies for HIV and operates in 16 countries. With [...]